News for Adagio Therapeutics Stock (ADGI)

ROSEN, A LEADING LAW FIRM, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI

PRNewsWire • 03/17/23

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI

PRNewsWire • 03/09/23

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI

PRNewsWire • 03/02/23

ROSEN, A TOP RANKED LAW FIRM, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI

PRNewsWire • 02/22/23

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI

PRNewsWire • 02/16/23

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI

Newsfile Corp • 02/13/23

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. - IVVD; ADGI

Newsfile Corp • 02/10/23

INVIVYD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI

Business Wire • 02/08/23

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 02/06/23

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI

PRNewsWire • 02/03/23

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Accesswire • 02/01/23

Invivyd Announces Multiple Next Generation COVID-19 Antibody Candidates and Selects Combination for Clinical Advancement Based on Positive in vitro Data Against Omicron Variants

GlobeNewsWire • 09/12/22

Adagio Therapeutics Announces Corporate Name Change to Invivyd

GlobeNewsWire • 09/12/22

Adagio Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewsWire • 09/06/22

Hedge Fund M28 Capital Increases Adagio Therapeutics (ADGI) Stake to 8.5%

24/7 Wall Street • 08/23/22

Adagio Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights

GlobeNewsWire • 08/15/22

Mithril Capital's Ajay Royan Sends Letter Thanking Adagio Therapeutics Shareholders for Support of Successful Proxy Campaign

Business Wire • 07/05/22

Adagio Announces David Hering Named Permanent Chief Executive Officer and Director

GlobeNewsWire • 07/05/22

(ADGI) News: Did You Lose Money on Your Adagio Therapeutics Investment? Stock Price has Plummeted Since IPO - Contact Johnson Fistel

Newsfile Corp • 07/03/22

Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors

GlobeNewsWire • 07/01/22

Adagio Therapeutics Reports First Quarter 2022 Financial Results

GlobeNewsWire • 05/13/22

Adagio Pauses FDA Emergency Use Request For Its COVID-19 Therapy

Benzinga • 04/14/22

Adagio Therapeutics Provides Update on Timing of Adintrevimab EUA Request

GlobeNewsWire • 04/14/22

Adagio's (ADGI) COVID-19 Antibody Meets Goals in Studies

Zacks Investment Research • 03/31/22

Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?

InvestorPlace • 03/30/22